Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe cases

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 64-69

  Lee, Kyung Yil ^a   Rhim, Jung Woo ^a   Kang, Jin Han ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISOLONE; RAG1 PROTEIN; TOLL LIKE RECEPTOR; TRIAMCINOLONE;

ACUTE LUNG INJURY; ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BRAIN DISEASE; CELLULAR IMMUNITY; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG USE; FEVER; GRANULOCYTE; HOMEOSTASIS; HOST CELL; HUMAN; HYPOTHESIS; INFLUENZA A (H1N1); INFLUENZA VIRUS A; INNATE IMMUNITY; KOREA; LEUKOCYTOSIS; LEUKOPENIA; LUNG ALVEOLUS CELL; LUNG INFILTRATE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MACROPHAGE; MONOCYTE; MUSCLE CELL; MYALGIA; NATURAL KILLER CELL; NERVE CELL; NEUTROPHIL; NONHUMAN; PANDEMIC INFLUENZA; PNEUMONIA; RESPIRATORY DISTRESS; RHABDOMYOLYSIS; SEPSIS; SYSTEMIC CIRCULATION; T LYMPHOCYTE; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REPLICATION;

ACUTE LUNG INJURY; ADJUVANTS, IMMUNOLOGIC; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; T-LYMPHOCYTES;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78650170982     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.032     Document Type: Article

References (55)

1. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
2. Dawood F.S., Jain S., Finell L., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
3. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
4. Renegar K.B. Influenza virus infections and immunity; a review of human and animal models. Lab Animal Sci 1992, 42:222-232.
5. Eichelberger M.C. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol 2007, 20:243-249.
6. Maines T.R., Jayaraman A., Belser J.A., et al. Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice. Science 2009, 325:484-487.
7. De Jong M.D., Simmons C.P., Thanh T.T., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207.
8. Yu H., Gao Z., Feng Z., et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 2008, 3:e2985.
9. Hien N.D., Ha N.H., Van N.T., et al. Human infection with highly pathogenic avian influenza virus (H5N1) in Northern Vietnam, 2004-2005. Emerg Infect Dis 2009, 15:19-23.
10. Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000, 74:6105-6116.
11. Lee K.Y., Lee H.S., Hur J.K., Kang J.H., Lee B.C. Clinical features of measles according to age in a measles epidemic. Scand J Infec Dis 2005, 37:471-475.
12. Peiris J.S., Chu C.M., Cheng V.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772.
13. Lee K.Y., Lee H.S., Hong J.H., et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006, 41:263-268.
14. Suzuki F., Ghya J., Ishida N. Effect of antilymphocyte serum on influenza virus infection in mice (38047). Proc Soc Exp Biol Med 1974, 146:78-84.
15. Wyde P.R., Couch R.B., Mackler B.F., Cate T.R., Levy B.M. Effect of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun 1977, 15:221-229.
16. La Gruta N.L., Kedzierska K., Stambas J., Doherty P. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007, 85:85-92.
17. Maines T.R., Szretter K.J., Peeone L., et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008, 225:68-84.
18. Lee KY, Hwang JY, Rhim JW, et al. Early corticoids treatment for severe pneumonia in children with novel swine-origin influenza A (H1N1) virus infection. In: Program and abstracts of the 28th annual meeting of the European society for pediatric infectious diseases, Nice, France: European Society of Pediatric Infectious Disease; 2010. p. 12.
19. Peiris J.S., de Jong M.D., Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007, 20:243-267.
20. Swayne D.E. Understanding the complex pathobiology of high pathogenisity avian influenza viruses in birds. Avian Dis 2007, 51:242-249.
21. Solomon R., Webster R.G. The Influenza virus enigma. Cell 2009, 136:402-410.
22. Wang J.P., Kurt-Jones E.A., Finberg R.W. Innate immunity to respiratory viruses. Cell Microbiol 2007, 9:1641-1646.
23. Eisenbarth S.C., Flavell R.A. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med 2009, 1:92-98.
24. Carty M, Bowie AG. Recent insights into the role of Toll-like receptors in viral infection. Clin Exp Immunol 2010; June 18 [Epub ahead of print] doi:10.1111/j.1365-2249.2010.04196.x.
25. Kris R.M., Yetter R.A., Cogliano R., Ramphal R., Small P.A. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Immunology 1988, 63:349-353.
26. Jamiesson A.M., Yu S., Annicelli C.H., Medzhitov R. Influenza virus-induced glucosteroids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 2010, 7:103-111.
27. Ottoini M.G., Blanco J.C.G., Eichelberger M.C., et al. Influenza virus pathogenesis in cotton rats: a useful small animal model for the study of disease and immunity. J Gen Virol 2005, 86:2823-2830.
28. Antonietta G, Andrea LV, Teresa RM, et al. Pandemic flu: a comparative evaluation of clinical, laboratory, and radiographic findings in HIV-positive and negative children. AIDS 2010; July 15 [Epub ahead of print].
29. Nichols J.E., Niles J.A., Roberts N.J. Human lymphocyte apoptosis after exposure to influenza A virus. J Virol 2001, 73:5921-5929.
30. Chen C.Y., Lee C.H., Liu C.Y., Wang J.H., Wang L.M., Perng R.P. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc 2005, 68:4-10.
31. Manocha S., Walley K.R., Russell J.A. Severe acute respiratory distress syndrome (SARS): a critical care perspective. Crit Care Med 2003, 31:2684-2692.
32. Sidorova L.A., Alekseyeva A.K. Experimental studies on influenza A2 virus infection after peroral inoculation. Acta Virol 1973, 17:293-297.
33. Banks RA. The enigma of influenzal pneumonia. Br J Hosp Med 1978;19:344, 346-50, 352.
34. Hers J.F., Goslings W.R., Masurel N., Mulder J. Death from Asiatic influenza in the Netherlands. Lancet 1957, 273(7006):1164-1165.
35. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008, 26:711-715.
36. Amarial M.C., Alves J.D. Pathogenesis of multi-organic failure in autoimmune disease. Autoimmun Rev 2009, 8:525-528.
37. Lee K.Y., Lee J.S. Immunoglobulin G has a role for systemic protein modulation in vivo: a new concept of protein homeostasis. Med Hypotheses 2006, 67:848-855.
38. Kim D.H., Lee S.W., Lee K.Y., et al. The change of immunologic parameters in acute poststreptococcal glomerulonephritis. J Korean Soc Pediatr Nephrol 2009, 13:138-145.
39. Lee K.Y. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008, 6:509-521.
40. Youn Y.S., Lee K.Y., Hwang J.Y., et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010, 10:48.
41. McGee S., Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008, 168:1034-1046.
42. Ottolini M., Blanco J., Porter D., Peterson L., Curtis S., Prince G. Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol 2003, 36:290-294.
43. Salomon R., Hoffmann E., Webster R.G. Inhibition of the cytokine response dose not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007, 104:12479-12481.
44. Quispe-Laime A.M., Bracco J.D., Barberio P.A., et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticoid treatment. Intensive Care Med 2010, 36:33-41.
45. To K.K., Hung I.F., Li I.W., et al. Delayed clearance of viral load and marked cytoline activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859.
46. Tang B.M.P., Craig J.C., Eslick G.D., Seppelt I., McLean A.S. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systemic review and meta-analysis. Crit Care Med 2009, 37:1594-1603.
47. Meduri G.U., Marik P.E., Annane D. Prolonged glucocorticoid treatment in acute respiratory distress syndrome: evidence supporting effectiveness and safety. Crit Care Med 2009, 37:1800-1803.
48. Kimmel E.C., Still K.R. Acute lung injuries, acute respiratory distress syndrome and inhalation injury: an overview. Dug Chem Toxicol 1999, 22:91-128.
49. Barnes P.J. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010, 120:76-85.
50. Bjelaković G., Stojanovic I., Jevtovic-Stoimenov T., et al. Thymus as a target tissue of glucocorticoid action: what are the consequences of glucocorticoids thymectomy?. J Basic Clin Physiol Pharmacol 2009, 20:99-125.
51. Sibéril S., Elluru S., Negi V.S., et al. Intravenous immunoglobulin in autoimmune and inflammatory disease: more than mere transfer of antibodies. Transfus Apher Sci 2007, 37:102-107.
52. Jordan S.C., Toyoda M., Vo A.A. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation 2009, 88:1-6.
53. Lee K.Y., Han J.W., Lee J.S. Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of environmental normal flora. Med Hypotheses 2007, 69:642-651.
54. White N.J., Webster R.G., Gonokova E.A., Uyeki T.M. What is the optimal therapy for patients with H5N1 influenza?. PLoS Med 2009, 6:e100091.
55. Falagas M.E., Vouloumanou E.K., Baskouta, et al. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Intern J Antimicrob Agents 2010, 35:421-430.